19937 results for «»

Filter By

19937 results

EBC MAIN trial results – what is new and what will change in left main stenting?

18 May 2021

The European Bifurcation Club Left Main (EBC MAIN) trial addressed the issue of provisional single stent versus upfront double stenting in 467 patients with true bifurcation distal left main disease. 

So far, only one other randomized trial, DKCRUSH-V (n=482), has addressed the same research question, showing better...

EBC MAIN trial results – what is new and what will change in left main stenting?

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

One-year results from the FUTURE-II trial

18 May 2021

A decade already passed from the first use of bioresorbable vascular scaffold in percutaneous coronary interventions. The first studies - by using surrogate endpoints - showed some superiority of BRS vs. metallic drug-eluting stent in terms of the so-called vascular restoration therapy with recovery of vasomotion...

One-year results from the FUTURE-II trial

A new meta-analysis supports elective revascularization and medical therapy for reducing cardiac death

18 May 2021

The ISCHEMIA trial found no significant difference between an invasive vs. a conservative strategy in patients with chronic coronary syndromes and moderate to severe ischemia at a mean of 3.2 years. However, the cumulative difference in the estimates of cardiac death between the invasive and conservative...

A new meta-analysis supports elective revascularization and medical therapy for reducing cardiac death

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

Artemio Garcia

Madrid, Spain

Kristy B. Garganera

Metro Manila, Philippines

Daniele Gemma

Madrid, Spain

Daniele Gemma

Sabine Genth-Zotz

Mainz, Germany

Islam Ghanem

Elsharkia, Egypt

Livia Luciana Gheorghe

Cádiz, Spain

Arijit Ghosh

Birmingham, United Kingdom

Federico Giacobbe

Metropolitan City of Turin, Italy

Federico Giacobbe

Mauro Gitto

Rozzano-Milan, Italy

Mauro Gitto

Tarantini Giuseppe

Padua, Italy

Gennaro Giustino

Detroit, United States of America

Piotr Godek

Katowice, Poland

Cosmo Godino

Milan, Italy

Dr. Cosmo Godino

Aisha Gohar

Milan, Italy

Ariana Gonzálvez García

Ciudad Real, Spain

Didn’t find what you were looking for?